z-logo
open-access-imgOpen Access
SARS-COV-2 VACCINE IN SPONDYLOARTHRITIS PATIENTS: OVERALL MODERATE/HIGH IMMUNOGENICITY IMPAIRED BY IMMUNOSUPPRESSANTS AND BIOLOGICAL THERAPY
Author(s) -
Carla Gonçalves Schahin Saad,
Matheus Santos Rodrigues Silva,
Percival D. SampaioBarros,
Júlio César Bertacini de Moraes,
Cláudia GoldensteinSchainberg,
Nádia Emi Aikawa,
Emily Figueiredo Neves Yuki,
Sandra Gofinet Pasoto,
Tatiana do Nascimento Pedrosa,
Renato Kenji Aoyama,
Carlo Scognamiglio Renner Araújo,
Clóvis Artur Almeida da Silva,
Ana Cristina de Medeiros Ribeiro,
Eloísa Bonfá
Publication year - 2021
Publication title -
sbr 2021 congresso brasileiro de reumatologia
Language(s) - English
Resource type - Conference proceedings
DOI - 10.47660/cbr.2021.2236
Subject(s) - immunogenicity , medicine , psoriatic arthritis , immunology , immune system , arthritis

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom